Literature DB >> 11324845

High-frequency (8 to 16 kHz) reference thresholds and intrasubject threshold variability relative to ototoxicity criteria using a Sennheiser HDA 200 earphone.

T Frank1.   

Abstract

OBJECTIVE: The first purpose of this study was to determine high-frequency (8 to 16 kHz) thresholds for standardizing reference equivalent threshold sound pressure levels (RETSPLs) for a Sennheiser HDA 200 earphone. The second and perhaps more important purpose of this study was to determine whether repeated high-frequency thresholds using a Sennheiser HDA 200 earphone had a lower intrasubject threshold variability than the ASHA 1994 significant threshold shift criteria for ototoxicity.
DESIGN: High-frequency thresholds (8 to 16 kHz) were obtained for 100 (50 male, 50 female) normally hearing (0.25 to 8 kHz) young adults (mean age of 21.2 yr) in four separate test sessions using a Sennheiser HDA 200 earphone.
RESULTS: The mean and median high-frequency thresholds were similar for each test session and increased as frequency increased. At each frequency, the high-frequency thresholds were not significantly (p > 0.05) different for gender, test ear, or test session. The median thresholds at each frequency were similar to the 1998 interim ISO RETSPLs; however, large standard deviations and wide threshold distributions indicated very high intersubject threshold variability, especially at 14 and 16 kHz. Threshold repeatability was determined by finding the threshold differences between each possible test session comparison (N = 6). About 98% of all of the threshold differences were within a clinically acceptable range of +/-10 dB from 8 to 14 kHz. The threshold differences between each subject's second, third, and fourth minus their first test session were also found to determine whether intrasubject threshold variability was less than the ASHA 1994 criteria for determining a significant threshold shift due to ototoxicity. The results indicated a false-positive rate of 0% for a threshold shift > or = 20 dB at any frequency and a false-positive rate of 2% for a threshold shift >10 dB at two consecutive frequencies.
CONCLUSIONS: This study verified that the output of high-frequency audiometers at 0 dB HL using Sennheiser HDA 200 earphones should equal the 1998 interim ISO RETSPLs from 8 to 16 kHz. Further, because the differences between repeated thresholds were well within +/-10 dB and had an extremely low false-positive rate in reference to the ASHA 1994 criteria for a significant threshold shift due to ototoxicity, a Sennheiser HDA 200 earphone can be used for serial monitoring to determine whether significant high-frequency threshold shifts have occurred for patients receiving potentially ototoxic drug therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324845     DOI: 10.1097/00003446-200104000-00009

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  16 in total

Review 1.  Drug-Induced Ototoxicity: Diagnosis and Monitoring.

Authors:  Kathleen C M Campbell; Colleen G Le Prell
Journal:  Drug Saf       Date:  2018-05       Impact factor: 5.606

2.  Temporary threshold shift after impulse-noise during video game play: laboratory data.

Authors:  C Spankovich; S K Griffiths; E Lobariñas; K E Morgenstein; S de la Calle; V Ledon; D Guercio; C G Le Prell
Journal:  Int J Audiol       Date:  2014-03       Impact factor: 2.117

3.  Short-term variability of pure-tone thresholds obtained with TDH-39P earphones.

Authors:  Gregory A Flamme; Mark R Stephenson; Kristy K Deiters; Amanda Hessenauer; Devon K VanGessel; Kyle Geda; Krista Wyllys; Kara D McGregor
Journal:  Int J Audiol       Date:  2014-03       Impact factor: 2.117

4.  High-frequency hearing thresholds: effects of age, occupational ultrasound and noise exposure.

Authors:  Isabella Maccà; Maria Luisa Scapellato; Mariella Carrieri; Stefano Maso; Andrea Trevisan; Giovanni Battista Bartolucci
Journal:  Int Arch Occup Environ Health       Date:  2014-06-13       Impact factor: 3.015

Review 5.  A Review of Cisplatin-Associated Ototoxicity.

Authors:  Jessica Paken; Cyril D Govender; Mershen Pillay; Vikash Sewram
Journal:  Semin Hear       Date:  2019-04-26

6.  Evaluation of audiometric threshold shift criteria for ototoxicity monitoring.

Authors:  Dawn Konrad-Martin; Kenneth E James; Jane S Gordon; Kelly M Reavis; David S Phillips; Gene W Bratt; Stephen A Fausti
Journal:  J Am Acad Audiol       Date:  2010-05       Impact factor: 1.664

7.  The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.

Authors:  Angela C Garinis; Campbell P Cross; Priya Srikanth; Kelly Carroll; M Patrick Feeney; Douglas H Keefe; Lisa L Hunter; Daniel B Putterman; David M Cohen; Jeffrey A Gold; Peter S Steyger
Journal:  J Cyst Fibros       Date:  2017-02-24       Impact factor: 5.482

Review 8.  Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.

Authors:  Dawn Konrad-Martin; Gayla L Poling; Angela C Garinis; Candice E Ortiz; Jennifer Hopper; Keri O'Connell Bennett; Marilyn F Dille
Journal:  Int J Audiol       Date:  2017-11-20       Impact factor: 2.117

9.  Extended high-frequency thresholds in college students: effects of music player use and other recreational noise.

Authors:  Colleen G Le Prell; Christopher Spankovich; Edward Lobariñas; Scott K Griffiths
Journal:  J Am Acad Audiol       Date:  2013-09       Impact factor: 1.664

10.  Extended high frequency hearing and speech perception implications in adults and children.

Authors:  Lisa L Hunter; Brian B Monson; David R Moore; Sumitrajit Dhar; Beverly A Wright; Kevin J Munro; Lina Motlagh Zadeh; Chelsea M Blankenship; Samantha M Stiepan; Jonathan H Siegel
Journal:  Hear Res       Date:  2020-02-18       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.